Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma

Completed · Phase 2

Conditions studied: Neuroblastoma

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. Peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy followed by peripheral stem cell transplantation in treating children who have newly diagnosed neuroblastoma.

Key facts

Study ID

NCT00017368

Run by

Children's Oncology Group

People needed

42

Starts

2001-04-01

Expected to finish

2012-01-01

Last updated by the study team

2014-02-13

Who can join

Age: any, up to 30. Sex: any. Healthy volunteers: not accepted.

Where it is running

• AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Scottish RiteCampus — Atlanta, Georgia, United States
• Floating Hospital for Children — Boston, Massachusetts, United States
• Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute — Boston, Massachusetts, United States
• CCOP - Columbia River Oncology Program — Portland, Oregon, United States
• Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States
• Baylor College of Medicine — Houston, Texas, United States
• CCOP - Scott and White Hospital — Temple, Texas, United States
• CCOP - Marshfield Clinic Research Foundation — Marshfield, Wisconsin, United States
• Princess Margaret Hospital for Children — Perth, Western Australia, Australia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.